US Stock MarketDetailed Quotes

KPTI Karyopharm Therapeutics

Watchlist
  • 0.818
  • -0.016-1.89%
Close Aug 16 16:00 ET
  • 0.815
  • -0.003-0.40%
Post 19:26 ET
102.03MMarket Cap-717P/E (TTM)

Karyopharm Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Karyopharm Therapeutics Q2 2024 Earnings Date

Currency：USDAug 6, 2024

Estimate
(YoY)		 Actual
(YoY)		 Vs Estimate
(% Chg)
Revenue
36.21M
42.79M
+6.57M
Beat Est.
-3.63%
+13.86%
+18.15%
EPS
-0.31
-0.20
+0.11
Beat Est.
-7.76%
+31.03%
+35.98%
Analyst Rating
Strong Buy

Aug 8, 2024

Karyopharm Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 6 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2024/Q4-- / 38.543M--
--2024/Q3-- / 38.118M--
Aug 6, 20242024/Q242.786M / 36.213M--
May 8, 20242024/Q133.126M / 34.473M--
Feb 29, 20242023/Q433.747M / 33.616M--
DatePeriodRevenue/EstimateEarnings Call
--2024/Q4-- / 38.543M--
--2024/Q3-- / 38.118M--
Aug 6, 20242024/Q242.786M / 36.213M--
May 8, 20242024/Q133.126M / 34.473M--
Feb 29, 20242023/Q433.747M / 33.616M--

Unlock Free Earnings Estimates

Karyopharm Therapeutics Earnings Reports

  • Karyopharm Therapeutics | 10-Q: Q2 2024 Earnings Report

    Aug 6 07:43 ET

  • Karyopharm Therapeutics | 10-Q: Q1 2024 Earnings Report

    May 8 17:18 ET

  • Karyopharm Therapeutics | 10-K: FY2023 Annual Report

    Feb 29 07:48 ET

  • Karyopharm Therapeutics | 10-Q: Q3 2023 Earnings Report

    Nov 2, 2023 07:57 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Aug 8, 2024

    Strong Buy

    • Buy

      80.00%

    • Hold

      20.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    % Chg